Calming and Sleeping in Switzerland

April 2015 | 27 pages | ID: C85BC10C875EN
Euromonitor International Ltd

Abstracts

Insomnia is a sleep disorder characterised by difficulty in falling and/or staying asleep. Swiss medical research has shown that after 40 years of age, 20% of women and 15% of men consider their sleep as being poor or very poor and one out of two people complain about sleep disorders at least once in his/her life. This situation is caused by many factors, such as daily problems, job pressure and stress as well as other conditions such as sleep apnea and environmental factors like noise, light,...

Euromonitor International's Calming and Sleeping in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Calming and Sleeping market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Calming and Sleeping: Value 2009-2014
  Table 2 Sales of Calming and Sleeping: % Value Growth 2009-2014
  Table 3 NBO Company Shares of Calming and Sleeping: % Value 2010-2014
  Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2011-2014
  Table 5 Forecast Sales of Calming and Sleeping: Value 2014-2019
  Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2014-2019
Bayer (schweiz) AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
Summary 1 Bayer (Schweiz) AG: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Bayer (Schweiz) AG: Competitive Position 2014
Novartis Consumer Health AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
Summary 3 Novartis Consumer Health AG: Key Facts
Summary 4 Novartis Consumer Health AG: Operational Indicators (worldwide)
Company Background
Production
Summary 5 Novartis Consumer Health AG: Production Statistics 2014
Competitive Positioning
Summary 6 Novartis Consumer Health AG: Competitive Position 2014
Vifor Pharma AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
Summary 7 Vifor Pharma AG: Key Facts
Summary 8 Vifor Pharma AG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 9 Vifor Pharma AG: Competitive Position 2014
Executive Summary
Consumer Health Industry Feels Impact of Authorities' Efforts To Control Health Costs
Switzerland's OTC Liberalisation Continues To Arouse Passionate Debate
Multinationals Dominate the Landscape in Consumer Health
Chemists/pharmacies Remains the Top Channel Amidst Challenge From Internet Retailing
Limited Prospects Over the Forecast Period
Key Trends and Developments
Economic Indicators Show Positive Trends in Consumer Health
Health and Wellness Trend A Positive Boost To Demand of Consumer Health Products
Liberalising the Sale of OTC Medicines: A Priority To Reduce Healthcare Costs
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
  Table 8 Life Expectancy at Birth 2009-2014
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2009-2014
  Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
  Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
  Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
  Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
  Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
  Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
  Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 10 OTC: Switches 2012-2014
Sources
Summary 11 Research Sources